Clinical Trial Update: Safety and Efficacy of a FAAH-Inhibitor to Treat Cannabis Withdrawal [Phase 2]

View source ↗

Summary

Phase 2 trial evaluating a FAAH inhibitor for treating cannabis withdrawal showed results after completion.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Cannabis Dependence

Drugs mentioned

• FAAH-inhibitor

Snippet

Sponsor: Yale University | Conditions: Cannabis Dependence | Phase 2 | Status: COMPLETED | Results posted: 2023-02-23